Copyright Reports & Markets. All rights reserved.

Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate by Type
    • 1.4.2 Aloxi (palonosetron)
    • 1.4.3 Kytril Generic (granisetron)
    • 1.4.4 Emend (aprepitant)
    • 1.4.5 Akynzeo (netupitant-palonosetron)
  • 1.5 Market by Application
    • 1.5.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate by Application
    • 1.5.2 Blood Cancer
    • 1.5.3 Breast Cancer
    • 1.5.4 Gastrointestinal Tract Cancer
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, Estimates and Forecasts
    • 2.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue 2015-2026
    • 2.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales 2015-2026
  • 2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitor Landscape by Players

  • 3.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Manufacturers
    • 3.1.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Manufacturers
    • 3.2.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue in 2019
    • 3.2.5 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Manufacturers
  • 3.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2015-2020)
    • 4.1.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2015-2020)
    • 5.1.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2015-2020)
  • 5.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Country
    • 6.1.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country
    • 6.1.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Type
  • 6.3 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Country
    • 7.1.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country
    • 7.1.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Type
  • 7.3 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Region
    • 8.1.1 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region
    • 8.1.2 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Type
  • 8.3 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Country
    • 9.1.1 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country
    • 9.1.2 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Type
  • 9.3 Central & South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Country
    • 10.1.1 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country
    • 10.1.2 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Type
  • 10.3 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Application

11 Company Profiles

  • 11.1 GlaxoSmithKline
    • 11.1.1 GlaxoSmithKline Corporation Information
    • 11.1.2 GlaxoSmithKline Description and Business Overview
    • 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GlaxoSmithKline Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
    • 11.1.5 GlaxoSmithKline Related Developments
  • 11.2 Helsinn
    • 11.2.1 Helsinn Corporation Information
    • 11.2.2 Helsinn Description and Business Overview
    • 11.2.3 Helsinn Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
    • 11.2.5 Helsinn Related Developments
  • 11.3 Heron Therapeutics
    • 11.3.1 Heron Therapeutics Corporation Information
    • 11.3.2 Heron Therapeutics Description and Business Overview
    • 11.3.3 Heron Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
    • 11.3.5 Heron Therapeutics Related Developments
  • 11.4 Merck & Co
    • 11.4.1 Merck & Co Corporation Information
    • 11.4.2 Merck & Co Description and Business Overview
    • 11.4.3 Merck & Co Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Merck & Co Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
    • 11.4.5 Merck & Co Related Developments
  • 11.5 Tesaro
    • 11.5.1 Tesaro Corporation Information
    • 11.5.2 Tesaro Description and Business Overview
    • 11.5.3 Tesaro Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Tesaro Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
    • 11.5.5 Tesaro Related Developments
  • 11.6 Acacia Pharma
    • 11.6.1 Acacia Pharma Corporation Information
    • 11.6.2 Acacia Pharma Description and Business Overview
    • 11.6.3 Acacia Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Acacia Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
    • 11.6.5 Acacia Pharma Related Developments
  • 11.7 Aphios
    • 11.7.1 Aphios Corporation Information
    • 11.7.2 Aphios Description and Business Overview
    • 11.7.3 Aphios Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Aphios Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
    • 11.7.5 Aphios Related Developments
  • 11.8 Barr Laboratories
    • 11.8.1 Barr Laboratories Corporation Information
    • 11.8.2 Barr Laboratories Description and Business Overview
    • 11.8.3 Barr Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Barr Laboratories Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
    • 11.8.5 Barr Laboratories Related Developments
  • 11.9 Baxter Healthcare
    • 11.9.1 Baxter Healthcare Corporation Information
    • 11.9.2 Baxter Healthcare Description and Business Overview
    • 11.9.3 Baxter Healthcare Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Baxter Healthcare Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
    • 11.9.5 Baxter Healthcare Related Developments
  • 11.10 Eisai
    • 11.10.1 Eisai Corporation Information
    • 11.10.2 Eisai Description and Business Overview
    • 11.10.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
    • 11.10.5 Eisai Related Developments
  • 11.1 GlaxoSmithKline
    • 11.1.1 GlaxoSmithKline Corporation Information
    • 11.1.2 GlaxoSmithKline Description and Business Overview
    • 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GlaxoSmithKline Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
    • 11.1.5 GlaxoSmithKline Related Developments
  • 11.12 F.Hoffmann La Roche
    • 11.12.1 F.Hoffmann La Roche Corporation Information
    • 11.12.2 F.Hoffmann La Roche Description and Business Overview
    • 11.12.3 F.Hoffmann La Roche Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 F.Hoffmann La Roche Products Offered
    • 11.12.5 F.Hoffmann La Roche Related Developments
  • 11.13 Mundipharma
    • 11.13.1 Mundipharma Corporation Information
    • 11.13.2 Mundipharma Description and Business Overview
    • 11.13.3 Mundipharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Mundipharma Products Offered
    • 11.13.5 Mundipharma Related Developments
  • 11.14 Mylan Pharmaceuticals
    • 11.14.1 Mylan Pharmaceuticals Corporation Information
    • 11.14.2 Mylan Pharmaceuticals Description and Business Overview
    • 11.14.3 Mylan Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Mylan Pharmaceuticals Products Offered
    • 11.14.5 Mylan Pharmaceuticals Related Developments
  • 11.15 OPKO Health
    • 11.15.1 OPKO Health Corporation Information
    • 11.15.2 OPKO Health Description and Business Overview
    • 11.15.3 OPKO Health Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 OPKO Health Products Offered
    • 11.15.5 OPKO Health Related Developments
  • 11.16 Orchid Healthcare
    • 11.16.1 Orchid Healthcare Corporation Information
    • 11.16.2 Orchid Healthcare Description and Business Overview
    • 11.16.3 Orchid Healthcare Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 Orchid Healthcare Products Offered
    • 11.16.5 Orchid Healthcare Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Estimates and Projections by Region
    • 12.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Regions 2021-2026
  • 12.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast (2021-2026)
    • 12.2.1 North America: Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast (2021-2026)
    • 12.2.2 North America: Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast (2021-2026)
    • 12.2.3 North America: Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast (2021-2026)
    • 12.3.2 Europe: Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market is segmented into
    Aloxi (palonosetron)
    Kytril Generic (granisetron)
    Emend (aprepitant)
    Akynzeo (netupitant-palonosetron)

    Segment by Application, the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market is segmented into
    Blood Cancer
    Breast Cancer
    Gastrointestinal Tract Cancer
    Others

    Regional and Country-level Analysis
    The Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share Analysis
    Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs business, the date to enter into the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs product introduction, recent developments, etc.

    The major vendors covered:
    GlaxoSmithKline
    Helsinn
    Heron Therapeutics
    Merck & Co
    Tesaro
    Acacia Pharma
    Aphios
    Barr Laboratories
    Baxter Healthcare
    Eisai
    Especificos Stendhal
    F.Hoffmann La Roche
    Mundipharma
    Mylan Pharmaceuticals
    OPKO Health
    Orchid Healthcare

    Buy now